Niina Aaltonen
Project Researcher
School of Medicine, Biomedicine
niina.aaltonen@uef.fi
Research groups
Publications
12 items-
The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study
Salmi, Satu; Lin, Anton; Hirschovits-Gerz, Benjamin; Valkonen, Mari; Aaltonen, Niina; Sironen, Reijo; Siiskonen, Hanna; Pasonen-Seppänen, Sanna. Bmc cancer 21 1: 641. 2021 -
High-Resolution Confocal Fluorescence Imaging of Serine Hydrolase Activity in Cryosections - Application to Glioma Brain Unveils Activity Hotspots Originating from Tumor-Associated Neutrophils
Aaltonen, Niina; Singha, Prosanta; Jakupovic, Hermina; Wirth, Thomas; Samaranayake, Haritha; Pasonen-Seppänen, Sanna; Rilla, Kirsi; Varjosalo, Markku; Edgington-Mitchell, Laura; Kasperkiewicz, Paulina; Drag, Marcin; Kälvälä, Sara; Moisio, Eemeli; Savinainen, Juha; Laitinen, Jarmo. Biological procedures online 22: 6. 2020 -
In vivo characterization of the ultrapotent monoacylglycerol lipase inhibitor {4-[bis-(benzo[d][1,3]dioxol-5-yl)methyl]-piperidin-1-yl} (1H-1,2,4-triazol-1-yl)methanone (JJKK-048)
Aaltonen Niina, Kedzierska Ewa, Orzelska-Gorka Jolanta, Lehtonen Marko, Navia-Paldanius Dina, Jakupovic Hermina, Savinainen Juha, Nevalainen Tapio, Laitinen Jarmo T, Parkkari Teija, Gynther Mikko. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 359: 62-72. 2016 -
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase
Navia-Paldanius Dina, Aaltonen Niina, Lehtonen Marko, Savinainen Juha R, Taschler Ulrike, Radner Franz PW, Zimmermann Robert, Laitinen Jarmo T. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 77: 180-188. 2015 -
Optimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors
Patel Jayendra Z, Nevalainen Tapio J, Savinainen Juha R, Adams Yahaya, Laitinen Tuomo, Runyon Robert S, Vaara Miia, Ahenkorah Stephen, Kaczor Agnieszka A, Navia-Paldanius Dina, Gynther Mikko, Aaltonen Niina, Joharapurkar Amit A, Jain Mukul R, Haka Abigail S, Maxfield Frederick R, Laitinen Jarmo T, Parkkari Teija. CHEMMEDCHEM 2015; 10 2: 253-265. 2014 -
Brain regional cannabinoid CB1 receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice
Aaltonen Niina, Ribas Casandra R, Lehtonen Marko, Savinainen Juha R, Laitinen Jarmo T. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 2014:51: 87-95. 2013 -
Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase
Aaltonen Niina, Savinainen Juha R, Ribas Casandra R, Rönkkö Jani, Kuusisto Anne, Korhonen Jani, Navia-Paldanius Dina, Häyrinen Jukka, Takabe Piia, Käsnänen Heikki, Pantsar Tatu, Laitinen Tuomo, Lehtonen Marko, Pasonen-Seppänen Sanna, Poso Antti, Nevalainen Tapio, Laitinen Jarmo T. CHEMISTRY AND BIOLOGY 20: 379-390. 2013 -
Functional Autoradiography as a Pharmacological Approach for Studying G Protein-Coupled Lipid Receptor Signalling
Aaltonen Niina. Publications of the University of Eastern Finland. Dissertations in Health Sciences 198. 2013 -
Quantification of endocannabinoids in postmortem brain of schizophrenic subjects
Muguruza Carolina, Lehtonen Marko, Aaltonen Niina, Morentin Benito, Meana J. Javier, Callado Luis F. SCHIZOPHRENIA RESEARCH (AMSTERDAM) 148: 145-150. 2013 -
Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation
Aaltonen Niina, Lehtonen Marko, Varonen Katri, Goterris Gemma Arrufat, Laitinen Jarmo T. BMC PHARMACOLOGY (ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCPHARMACOL/] 12: 7. 2012